nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabigatran etexilate—UGT2B15—Valproic Acid—epilepsy syndrome	0.134	0.232	CbGbCtD
Dabigatran etexilate—CES1—Rufinamide—epilepsy syndrome	0.125	0.217	CbGbCtD
Dabigatran etexilate—ABCB1—epilepsy syndrome	0.116	1	CbGaD
Dabigatran etexilate—UGT2B7—Carbamazepine—epilepsy syndrome	0.0701	0.121	CbGbCtD
Dabigatran etexilate—UGT1A9—Propofol—epilepsy syndrome	0.062	0.107	CbGbCtD
Dabigatran etexilate—UGT1A9—Valproic Acid—epilepsy syndrome	0.0442	0.0766	CbGbCtD
Dabigatran etexilate—UGT2B7—Valproic Acid—epilepsy syndrome	0.0419	0.0725	CbGbCtD
Dabigatran etexilate—ABCB1—Levetiracetam—epilepsy syndrome	0.0209	0.0362	CbGbCtD
Dabigatran etexilate—ABCB1—Clobazam—epilepsy syndrome	0.0145	0.0251	CbGbCtD
Dabigatran etexilate—ABCB1—Lamotrigine—epilepsy syndrome	0.014	0.0242	CbGbCtD
Dabigatran etexilate—ABCB1—Carbamazepine—epilepsy syndrome	0.012	0.0208	CbGbCtD
Dabigatran etexilate—ABCB1—Phenytoin—epilepsy syndrome	0.0108	0.0186	CbGbCtD
Dabigatran etexilate—ABCB1—Phenobarbital—epilepsy syndrome	0.0096	0.0166	CbGbCtD
Dabigatran etexilate—ABCB1—Midazolam—epilepsy syndrome	0.00947	0.0164	CbGbCtD
Dabigatran etexilate—ABCB1—Diazepam—epilepsy syndrome	0.0091	0.0158	CbGbCtD
Dabigatran etexilate—F2—forelimb—epilepsy syndrome	0.00512	0.177	CbGeAlD
Dabigatran etexilate—NQO2—hindbrain—epilepsy syndrome	0.00209	0.0725	CbGeAlD
Dabigatran etexilate—NQO2—brainstem—epilepsy syndrome	0.0012	0.0415	CbGeAlD
Dabigatran etexilate—CES2—telencephalon—epilepsy syndrome	0.00119	0.0412	CbGeAlD
Dabigatran etexilate—NQO2—telencephalon—epilepsy syndrome	0.00106	0.0369	CbGeAlD
Dabigatran etexilate—CES2—medulla oblongata—epilepsy syndrome	0.000934	0.0324	CbGeAlD
Dabigatran etexilate—CES2—midbrain—epilepsy syndrome	0.000854	0.0296	CbGeAlD
Dabigatran etexilate—NQO2—medulla oblongata—epilepsy syndrome	0.000835	0.029	CbGeAlD
Dabigatran etexilate—CES2—spinal cord—epilepsy syndrome	0.000833	0.0289	CbGeAlD
Dabigatran etexilate—NQO2—midbrain—epilepsy syndrome	0.000763	0.0265	CbGeAlD
Dabigatran etexilate—F2—spinal cord—epilepsy syndrome	0.000747	0.0259	CbGeAlD
Dabigatran etexilate—NQO2—spinal cord—epilepsy syndrome	0.000744	0.0258	CbGeAlD
Dabigatran etexilate—CES2—head—epilepsy syndrome	0.00074	0.0257	CbGeAlD
Dabigatran etexilate—CES2—nervous system—epilepsy syndrome	0.000702	0.0243	CbGeAlD
Dabigatran etexilate—CES2—central nervous system—epilepsy syndrome	0.000676	0.0234	CbGeAlD
Dabigatran etexilate—F2—head—epilepsy syndrome	0.000664	0.023	CbGeAlD
Dabigatran etexilate—NQO2—head—epilepsy syndrome	0.000662	0.0229	CbGeAlD
Dabigatran etexilate—CES2—cerebellum—epilepsy syndrome	0.00066	0.0229	CbGeAlD
Dabigatran etexilate—F2—nervous system—epilepsy syndrome	0.00063	0.0218	CbGeAlD
Dabigatran etexilate—NQO2—nervous system—epilepsy syndrome	0.000627	0.0218	CbGeAlD
Dabigatran etexilate—CES1—head—epilepsy syndrome	0.00061	0.0211	CbGeAlD
Dabigatran etexilate—F2—central nervous system—epilepsy syndrome	0.000606	0.021	CbGeAlD
Dabigatran etexilate—NQO2—central nervous system—epilepsy syndrome	0.000604	0.0209	CbGeAlD
Dabigatran etexilate—NQO2—cerebellum—epilepsy syndrome	0.00059	0.0205	CbGeAlD
Dabigatran etexilate—CES1—nervous system—epilepsy syndrome	0.000578	0.0201	CbGeAlD
Dabigatran etexilate—CES1—central nervous system—epilepsy syndrome	0.000556	0.0193	CbGeAlD
Dabigatran etexilate—CES2—brain—epilepsy syndrome	0.000536	0.0186	CbGeAlD
Dabigatran etexilate—F2—brain—epilepsy syndrome	0.000481	0.0167	CbGeAlD
Dabigatran etexilate—NQO2—brain—epilepsy syndrome	0.000479	0.0166	CbGeAlD
Dabigatran etexilate—CES1—brain—epilepsy syndrome	0.000442	0.0153	CbGeAlD
Dabigatran etexilate—ABCB1—forebrain—epilepsy syndrome	0.000249	0.00865	CbGeAlD
Dabigatran etexilate—ABCB1—telencephalon—epilepsy syndrome	0.000229	0.00796	CbGeAlD
Dabigatran etexilate—ABCB1—medulla oblongata—epilepsy syndrome	0.00018	0.00625	CbGeAlD
Dabigatran etexilate—ABCB1—midbrain—epilepsy syndrome	0.000165	0.00571	CbGeAlD
Dabigatran etexilate—ABCB1—spinal cord—epilepsy syndrome	0.000161	0.00557	CbGeAlD
Dabigatran etexilate—ABCB1—head—epilepsy syndrome	0.000143	0.00495	CbGeAlD
Dabigatran etexilate—ABCB1—nervous system—epilepsy syndrome	0.000135	0.0047	CbGeAlD
Dabigatran etexilate—ABCB1—central nervous system—epilepsy syndrome	0.00013	0.00452	CbGeAlD
Dabigatran etexilate—ABCB1—cerebellum—epilepsy syndrome	0.000127	0.00442	CbGeAlD
Dabigatran etexilate—ABCB1—brain—epilepsy syndrome	0.000103	0.00359	CbGeAlD
Dabigatran etexilate—Rash—Midazolam—epilepsy syndrome	8.93e-05	0.000467	CcSEcCtD
Dabigatran etexilate—Dizziness—Fosphenytoin—epilepsy syndrome	8.93e-05	0.000466	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	8.92e-05	0.000466	CcSEcCtD
Dabigatran etexilate—Dermatitis—Midazolam—epilepsy syndrome	8.92e-05	0.000466	CcSEcCtD
Dabigatran etexilate—Urticaria—Carbamazepine—epilepsy syndrome	8.91e-05	0.000466	CcSEcCtD
Dabigatran etexilate—Vomiting—Levetiracetam—epilepsy syndrome	8.9e-05	0.000465	CcSEcCtD
Dabigatran etexilate—Epistaxis—Topiramate—epilepsy syndrome	8.89e-05	0.000464	CcSEcCtD
Dabigatran etexilate—Headache—Midazolam—epilepsy syndrome	8.88e-05	0.000464	CcSEcCtD
Dabigatran etexilate—Pruritus—Felbamate—epilepsy syndrome	8.87e-05	0.000464	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Carbamazepine—epilepsy syndrome	8.87e-05	0.000463	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Diazepam—epilepsy syndrome	8.87e-05	0.000463	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	8.87e-05	0.000463	CcSEcCtD
Dabigatran etexilate—Sinusitis—Topiramate—epilepsy syndrome	8.84e-05	0.000462	CcSEcCtD
Dabigatran etexilate—Rash—Levetiracetam—epilepsy syndrome	8.82e-05	0.000461	CcSEcCtD
Dabigatran etexilate—Anaemia—Pregabalin—epilepsy syndrome	8.82e-05	0.000461	CcSEcCtD
Dabigatran etexilate—Dermatitis—Levetiracetam—epilepsy syndrome	8.81e-05	0.00046	CcSEcCtD
Dabigatran etexilate—Asthenia—Zonisamide—epilepsy syndrome	8.81e-05	0.00046	CcSEcCtD
Dabigatran etexilate—Headache—Levetiracetam—epilepsy syndrome	8.76e-05	0.000458	CcSEcCtD
Dabigatran etexilate—Malnutrition—Gabapentin—epilepsy syndrome	8.75e-05	0.000457	CcSEcCtD
Dabigatran etexilate—Angioedema—Pregabalin—epilepsy syndrome	8.72e-05	0.000456	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Clonazepam—epilepsy syndrome	8.72e-05	0.000455	CcSEcCtD
Dabigatran etexilate—Dizziness—Vigabatrin—epilepsy syndrome	8.7e-05	0.000455	CcSEcCtD
Dabigatran etexilate—Pruritus—Zonisamide—epilepsy syndrome	8.69e-05	0.000454	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Phenytoin—epilepsy syndrome	8.66e-05	0.000452	CcSEcCtD
Dabigatran etexilate—Flatulence—Gabapentin—epilepsy syndrome	8.62e-05	0.000451	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Valproic Acid—epilepsy syndrome	8.62e-05	0.00045	CcSEcCtD
Dabigatran etexilate—Urticaria—Lamotrigine—epilepsy syndrome	8.61e-05	0.00045	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	8.61e-05	0.00045	CcSEcCtD
Dabigatran etexilate—Nausea—Propofol—epilepsy syndrome	8.6e-05	0.000449	CcSEcCtD
Dabigatran etexilate—Vomiting—Fosphenytoin—epilepsy syndrome	8.59e-05	0.000449	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Felbamate—epilepsy syndrome	8.58e-05	0.000448	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Lamotrigine—epilepsy syndrome	8.57e-05	0.000448	CcSEcCtD
Dabigatran etexilate—Dizziness—Diazepam—epilepsy syndrome	8.57e-05	0.000448	CcSEcCtD
Dabigatran etexilate—Infection—Valproic Acid—epilepsy syndrome	8.56e-05	0.000447	CcSEcCtD
Dabigatran etexilate—Syncope—Pregabalin—epilepsy syndrome	8.56e-05	0.000447	CcSEcCtD
Dabigatran etexilate—Rash—Fosphenytoin—epilepsy syndrome	8.51e-05	0.000445	CcSEcCtD
Dabigatran etexilate—Dermatitis—Fosphenytoin—epilepsy syndrome	8.51e-05	0.000444	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Topiramate—epilepsy syndrome	8.5e-05	0.000444	CcSEcCtD
Dabigatran etexilate—Asthenia—Clonazepam—epilepsy syndrome	8.49e-05	0.000443	CcSEcCtD
Dabigatran etexilate—Back pain—Gabapentin—epilepsy syndrome	8.46e-05	0.000442	CcSEcCtD
Dabigatran etexilate—Headache—Fosphenytoin—epilepsy syndrome	8.46e-05	0.000442	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Topiramate—epilepsy syndrome	8.46e-05	0.000442	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Valproic Acid—epilepsy syndrome	8.45e-05	0.000441	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Valproic Acid—epilepsy syndrome	8.44e-05	0.000441	CcSEcCtD
Dabigatran etexilate—Palpitations—Pregabalin—epilepsy syndrome	8.43e-05	0.000441	CcSEcCtD
Dabigatran etexilate—Asthenia—Phenytoin—epilepsy syndrome	8.43e-05	0.000441	CcSEcCtD
Dabigatran etexilate—Nausea—Midazolam—epilepsy syndrome	8.42e-05	0.00044	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Zonisamide—epilepsy syndrome	8.4e-05	0.000439	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Pregabalin—epilepsy syndrome	8.39e-05	0.000438	CcSEcCtD
Dabigatran etexilate—Asthenia—Oxcarbazepine—epilepsy syndrome	8.39e-05	0.000438	CcSEcCtD
Dabigatran etexilate—Pruritus—Clonazepam—epilepsy syndrome	8.37e-05	0.000437	CcSEcCtD
Dabigatran etexilate—Vomiting—Vigabatrin—epilepsy syndrome	8.37e-05	0.000437	CcSEcCtD
Dabigatran etexilate—Skin disorder—Valproic Acid—epilepsy syndrome	8.37e-05	0.000437	CcSEcCtD
Dabigatran etexilate—Urinary tract disorder—Topiramate—epilepsy syndrome	8.35e-05	0.000436	CcSEcCtD
Dabigatran etexilate—Oedema peripheral—Topiramate—epilepsy syndrome	8.33e-05	0.000435	CcSEcCtD
Dabigatran etexilate—Cough—Pregabalin—epilepsy syndrome	8.33e-05	0.000435	CcSEcCtD
Dabigatran etexilate—Pruritus—Phenytoin—epilepsy syndrome	8.31e-05	0.000434	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Topiramate—epilepsy syndrome	8.31e-05	0.000434	CcSEcCtD
Dabigatran etexilate—Nausea—Levetiracetam—epilepsy syndrome	8.31e-05	0.000434	CcSEcCtD
Dabigatran etexilate—Rash—Vigabatrin—epilepsy syndrome	8.3e-05	0.000434	CcSEcCtD
Dabigatran etexilate—Dizziness—Felbamate—epilepsy syndrome	8.29e-05	0.000433	CcSEcCtD
Dabigatran etexilate—Dermatitis—Vigabatrin—epilepsy syndrome	8.29e-05	0.000433	CcSEcCtD
Dabigatran etexilate—Urethral disorder—Topiramate—epilepsy syndrome	8.29e-05	0.000433	CcSEcCtD
Dabigatran etexilate—Pruritus—Oxcarbazepine—epilepsy syndrome	8.27e-05	0.000432	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Carbamazepine—epilepsy syndrome	8.26e-05	0.000432	CcSEcCtD
Dabigatran etexilate—Headache—Vigabatrin—epilepsy syndrome	8.25e-05	0.000431	CcSEcCtD
Dabigatran etexilate—Hypertension—Pregabalin—epilepsy syndrome	8.24e-05	0.00043	CcSEcCtD
Dabigatran etexilate—Vomiting—Diazepam—epilepsy syndrome	8.24e-05	0.00043	CcSEcCtD
Dabigatran etexilate—Rash—Diazepam—epilepsy syndrome	8.17e-05	0.000427	CcSEcCtD
Dabigatran etexilate—Dermatitis—Diazepam—epilepsy syndrome	8.16e-05	0.000426	CcSEcCtD
Dabigatran etexilate—Chest pain—Pregabalin—epilepsy syndrome	8.12e-05	0.000424	CcSEcCtD
Dabigatran etexilate—Arthralgia—Pregabalin—epilepsy syndrome	8.12e-05	0.000424	CcSEcCtD
Dabigatran etexilate—Dizziness—Zonisamide—epilepsy syndrome	8.12e-05	0.000424	CcSEcCtD
Dabigatran etexilate—Headache—Diazepam—epilepsy syndrome	8.12e-05	0.000424	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Clonazepam—epilepsy syndrome	8.09e-05	0.000423	CcSEcCtD
Dabigatran etexilate—Anaemia—Gabapentin—epilepsy syndrome	8.09e-05	0.000423	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	8.07e-05	0.000422	CcSEcCtD
Dabigatran etexilate—Hypotension—Valproic Acid—epilepsy syndrome	8.05e-05	0.000421	CcSEcCtD
Dabigatran etexilate—Asthenia—Carbamazepine—epilepsy syndrome	8.05e-05	0.00042	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Phenytoin—epilepsy syndrome	8.04e-05	0.00042	CcSEcCtD
Dabigatran etexilate—Nausea—Fosphenytoin—epilepsy syndrome	8.02e-05	0.000419	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Oxcarbazepine—epilepsy syndrome	8e-05	0.000418	CcSEcCtD
Dabigatran etexilate—Angioedema—Gabapentin—epilepsy syndrome	8e-05	0.000418	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Lamotrigine—epilepsy syndrome	7.99e-05	0.000417	CcSEcCtD
Dabigatran etexilate—Vomiting—Felbamate—epilepsy syndrome	7.97e-05	0.000417	CcSEcCtD
Dabigatran etexilate—Pruritus—Carbamazepine—epilepsy syndrome	7.94e-05	0.000415	CcSEcCtD
Dabigatran etexilate—Rash—Felbamate—epilepsy syndrome	7.91e-05	0.000413	CcSEcCtD
Dabigatran etexilate—Dermatitis—Felbamate—epilepsy syndrome	7.9e-05	0.000413	CcSEcCtD
Dabigatran etexilate—Headache—Felbamate—epilepsy syndrome	7.86e-05	0.00041	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	7.85e-05	0.00041	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Topiramate—epilepsy syndrome	7.85e-05	0.00041	CcSEcCtD
Dabigatran etexilate—Syncope—Gabapentin—epilepsy syndrome	7.85e-05	0.00041	CcSEcCtD
Dabigatran etexilate—Dizziness—Clonazepam—epilepsy syndrome	7.82e-05	0.000409	CcSEcCtD
Dabigatran etexilate—Nausea—Vigabatrin—epilepsy syndrome	7.82e-05	0.000408	CcSEcCtD
Dabigatran etexilate—Vomiting—Zonisamide—epilepsy syndrome	7.81e-05	0.000408	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Pregabalin—epilepsy syndrome	7.79e-05	0.000407	CcSEcCtD
Dabigatran etexilate—Asthenia—Lamotrigine—epilepsy syndrome	7.78e-05	0.000406	CcSEcCtD
Dabigatran etexilate—Dizziness—Phenytoin—epilepsy syndrome	7.77e-05	0.000406	CcSEcCtD
Dabigatran etexilate—Rash—Zonisamide—epilepsy syndrome	7.74e-05	0.000404	CcSEcCtD
Dabigatran etexilate—Infection—Pregabalin—epilepsy syndrome	7.74e-05	0.000404	CcSEcCtD
Dabigatran etexilate—Palpitations—Gabapentin—epilepsy syndrome	7.73e-05	0.000404	CcSEcCtD
Dabigatran etexilate—Dermatitis—Zonisamide—epilepsy syndrome	7.73e-05	0.000404	CcSEcCtD
Dabigatran etexilate—Dizziness—Oxcarbazepine—epilepsy syndrome	7.73e-05	0.000404	CcSEcCtD
Dabigatran etexilate—Nausea—Diazepam—epilepsy syndrome	7.7e-05	0.000402	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Gabapentin—epilepsy syndrome	7.69e-05	0.000402	CcSEcCtD
Dabigatran etexilate—Headache—Zonisamide—epilepsy syndrome	7.69e-05	0.000402	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Valproic Acid—epilepsy syndrome	7.68e-05	0.000401	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Carbamazepine—epilepsy syndrome	7.68e-05	0.000401	CcSEcCtD
Dabigatran etexilate—Angiopathy—Topiramate—epilepsy syndrome	7.67e-05	0.000401	CcSEcCtD
Dabigatran etexilate—Pruritus—Lamotrigine—epilepsy syndrome	7.67e-05	0.000401	CcSEcCtD
Dabigatran etexilate—Shock—Pregabalin—epilepsy syndrome	7.66e-05	0.0004	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Topiramate—epilepsy syndrome	7.64e-05	0.000399	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Pregabalin—epilepsy syndrome	7.64e-05	0.000399	CcSEcCtD
Dabigatran etexilate—Cough—Gabapentin—epilepsy syndrome	7.64e-05	0.000399	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Pregabalin—epilepsy syndrome	7.63e-05	0.000398	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Topiramate—epilepsy syndrome	7.62e-05	0.000398	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Valproic Acid—epilepsy syndrome	7.58e-05	0.000396	CcSEcCtD
Dabigatran etexilate—Skin disorder—Pregabalin—epilepsy syndrome	7.57e-05	0.000395	CcSEcCtD
Dabigatran etexilate—Hypertension—Gabapentin—epilepsy syndrome	7.56e-05	0.000395	CcSEcCtD
Dabigatran etexilate—Vomiting—Clonazepam—epilepsy syndrome	7.52e-05	0.000393	CcSEcCtD
Dabigatran etexilate—Vomiting—Phenytoin—epilepsy syndrome	7.47e-05	0.00039	CcSEcCtD
Dabigatran etexilate—Rash—Clonazepam—epilepsy syndrome	7.46e-05	0.00039	CcSEcCtD
Dabigatran etexilate—Dermatitis—Clonazepam—epilepsy syndrome	7.45e-05	0.000389	CcSEcCtD
Dabigatran etexilate—Chest pain—Gabapentin—epilepsy syndrome	7.45e-05	0.000389	CcSEcCtD
Dabigatran etexilate—Arthralgia—Gabapentin—epilepsy syndrome	7.45e-05	0.000389	CcSEcCtD
Dabigatran etexilate—Nausea—Felbamate—epilepsy syndrome	7.45e-05	0.000389	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	7.44e-05	0.000389	CcSEcCtD
Dabigatran etexilate—Vomiting—Oxcarbazepine—epilepsy syndrome	7.43e-05	0.000388	CcSEcCtD
Dabigatran etexilate—Fatigue—Valproic Acid—epilepsy syndrome	7.43e-05	0.000388	CcSEcCtD
Dabigatran etexilate—Dizziness—Carbamazepine—epilepsy syndrome	7.42e-05	0.000388	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Lamotrigine—epilepsy syndrome	7.42e-05	0.000388	CcSEcCtD
Dabigatran etexilate—Headache—Clonazepam—epilepsy syndrome	7.41e-05	0.000387	CcSEcCtD
Dabigatran etexilate—Rash—Phenytoin—epilepsy syndrome	7.41e-05	0.000387	CcSEcCtD
Dabigatran etexilate—Dermatitis—Phenytoin—epilepsy syndrome	7.4e-05	0.000387	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	7.4e-05	0.000387	CcSEcCtD
Dabigatran etexilate—Rash—Oxcarbazepine—epilepsy syndrome	7.37e-05	0.000385	CcSEcCtD
Dabigatran etexilate—Constipation—Valproic Acid—epilepsy syndrome	7.37e-05	0.000385	CcSEcCtD
Dabigatran etexilate—Dermatitis—Oxcarbazepine—epilepsy syndrome	7.36e-05	0.000385	CcSEcCtD
Dabigatran etexilate—Headache—Phenytoin—epilepsy syndrome	7.36e-05	0.000385	CcSEcCtD
Dabigatran etexilate—Malnutrition—Topiramate—epilepsy syndrome	7.36e-05	0.000385	CcSEcCtD
Dabigatran etexilate—Headache—Oxcarbazepine—epilepsy syndrome	7.32e-05	0.000383	CcSEcCtD
Dabigatran etexilate—Nausea—Zonisamide—epilepsy syndrome	7.29e-05	0.000381	CcSEcCtD
Dabigatran etexilate—Hypotension—Pregabalin—epilepsy syndrome	7.28e-05	0.00038	CcSEcCtD
Dabigatran etexilate—Flatulence—Topiramate—epilepsy syndrome	7.25e-05	0.000379	CcSEcCtD
Dabigatran etexilate—Dizziness—Lamotrigine—epilepsy syndrome	7.17e-05	0.000375	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Gabapentin—epilepsy syndrome	7.14e-05	0.000373	CcSEcCtD
Dabigatran etexilate—Vomiting—Carbamazepine—epilepsy syndrome	7.13e-05	0.000373	CcSEcCtD
Dabigatran etexilate—Back pain—Topiramate—epilepsy syndrome	7.12e-05	0.000372	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	7.1e-05	0.000371	CcSEcCtD
Dabigatran etexilate—Infection—Gabapentin—epilepsy syndrome	7.1e-05	0.000371	CcSEcCtD
Dabigatran etexilate—Rash—Carbamazepine—epilepsy syndrome	7.07e-05	0.00037	CcSEcCtD
Dabigatran etexilate—Dermatitis—Carbamazepine—epilepsy syndrome	7.07e-05	0.000369	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	7.04e-05	0.000368	CcSEcCtD
Dabigatran etexilate—Nausea—Clonazepam—epilepsy syndrome	7.03e-05	0.000367	CcSEcCtD
Dabigatran etexilate—Headache—Carbamazepine—epilepsy syndrome	7.03e-05	0.000367	CcSEcCtD
Dabigatran etexilate—Shock—Gabapentin—epilepsy syndrome	7.03e-05	0.000367	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Gabapentin—epilepsy syndrome	7e-05	0.000366	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Gabapentin—epilepsy syndrome	6.99e-05	0.000365	CcSEcCtD
Dabigatran etexilate—Nausea—Phenytoin—epilepsy syndrome	6.98e-05	0.000365	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Pregabalin—epilepsy syndrome	6.94e-05	0.000363	CcSEcCtD
Dabigatran etexilate—Nausea—Oxcarbazepine—epilepsy syndrome	6.94e-05	0.000363	CcSEcCtD
Dabigatran etexilate—Skin disorder—Gabapentin—epilepsy syndrome	6.94e-05	0.000362	CcSEcCtD
Dabigatran etexilate—Vomiting—Lamotrigine—epilepsy syndrome	6.89e-05	0.00036	CcSEcCtD
Dabigatran etexilate—Urticaria—Valproic Acid—epilepsy syndrome	6.84e-05	0.000358	CcSEcCtD
Dabigatran etexilate—Rash—Lamotrigine—epilepsy syndrome	6.84e-05	0.000357	CcSEcCtD
Dabigatran etexilate—Dermatitis—Lamotrigine—epilepsy syndrome	6.83e-05	0.000357	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Valproic Acid—epilepsy syndrome	6.81e-05	0.000356	CcSEcCtD
Dabigatran etexilate—Anaemia—Topiramate—epilepsy syndrome	6.8e-05	0.000356	CcSEcCtD
Dabigatran etexilate—Headache—Lamotrigine—epilepsy syndrome	6.79e-05	0.000355	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	6.72e-05	0.000351	CcSEcCtD
Dabigatran etexilate—Fatigue—Pregabalin—epilepsy syndrome	6.71e-05	0.000351	CcSEcCtD
Dabigatran etexilate—Hypotension—Gabapentin—epilepsy syndrome	6.67e-05	0.000349	CcSEcCtD
Dabigatran etexilate—Nausea—Carbamazepine—epilepsy syndrome	6.66e-05	0.000348	CcSEcCtD
Dabigatran etexilate—Constipation—Pregabalin—epilepsy syndrome	6.66e-05	0.000348	CcSEcCtD
Dabigatran etexilate—Syncope—Topiramate—epilepsy syndrome	6.6e-05	0.000345	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	6.51e-05	0.00034	CcSEcCtD
Dabigatran etexilate—Palpitations—Topiramate—epilepsy syndrome	6.51e-05	0.00034	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Topiramate—epilepsy syndrome	6.47e-05	0.000338	CcSEcCtD
Dabigatran etexilate—Nausea—Lamotrigine—epilepsy syndrome	6.44e-05	0.000336	CcSEcCtD
Dabigatran etexilate—Cough—Topiramate—epilepsy syndrome	6.42e-05	0.000336	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Pregabalin—epilepsy syndrome	6.37e-05	0.000333	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Gabapentin—epilepsy syndrome	6.37e-05	0.000333	CcSEcCtD
Dabigatran etexilate—Hypertension—Topiramate—epilepsy syndrome	6.36e-05	0.000332	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Valproic Acid—epilepsy syndrome	6.35e-05	0.000332	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Gabapentin—epilepsy syndrome	6.29e-05	0.000328	CcSEcCtD
Dabigatran etexilate—Chest pain—Topiramate—epilepsy syndrome	6.27e-05	0.000327	CcSEcCtD
Dabigatran etexilate—Arthralgia—Topiramate—epilepsy syndrome	6.27e-05	0.000327	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	6.22e-05	0.000325	CcSEcCtD
Dabigatran etexilate—Urticaria—Pregabalin—epilepsy syndrome	6.19e-05	0.000323	CcSEcCtD
Dabigatran etexilate—Asthenia—Valproic Acid—epilepsy syndrome	6.18e-05	0.000323	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	6.17e-05	0.000322	CcSEcCtD
Dabigatran etexilate—Fatigue—Gabapentin—epilepsy syndrome	6.16e-05	0.000322	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Pregabalin—epilepsy syndrome	6.16e-05	0.000322	CcSEcCtD
Dabigatran etexilate—Constipation—Gabapentin—epilepsy syndrome	6.11e-05	0.000319	CcSEcCtD
Dabigatran etexilate—Pruritus—Valproic Acid—epilepsy syndrome	6.1e-05	0.000318	CcSEcCtD
Dabigatran etexilate—Infection—Topiramate—epilepsy syndrome	5.97e-05	0.000312	CcSEcCtD
Dabigatran etexilate—Shock—Topiramate—epilepsy syndrome	5.91e-05	0.000309	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Valproic Acid—epilepsy syndrome	5.89e-05	0.000308	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Topiramate—epilepsy syndrome	5.89e-05	0.000308	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Topiramate—epilepsy syndrome	5.88e-05	0.000307	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Gabapentin—epilepsy syndrome	5.84e-05	0.000305	CcSEcCtD
Dabigatran etexilate—Skin disorder—Topiramate—epilepsy syndrome	5.84e-05	0.000305	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Pregabalin—epilepsy syndrome	5.74e-05	0.0003	CcSEcCtD
Dabigatran etexilate—Dizziness—Valproic Acid—epilepsy syndrome	5.7e-05	0.000298	CcSEcCtD
Dabigatran etexilate—Urticaria—Gabapentin—epilepsy syndrome	5.67e-05	0.000296	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Gabapentin—epilepsy syndrome	5.65e-05	0.000295	CcSEcCtD
Dabigatran etexilate—Hypotension—Topiramate—epilepsy syndrome	5.61e-05	0.000293	CcSEcCtD
Dabigatran etexilate—Asthenia—Pregabalin—epilepsy syndrome	5.59e-05	0.000292	CcSEcCtD
Dabigatran etexilate—Pruritus—Pregabalin—epilepsy syndrome	5.51e-05	0.000288	CcSEcCtD
Dabigatran etexilate—Vomiting—Valproic Acid—epilepsy syndrome	5.48e-05	0.000286	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	5.47e-05	0.000286	CcSEcCtD
Dabigatran etexilate—Rash—Valproic Acid—epilepsy syndrome	5.43e-05	0.000284	CcSEcCtD
Dabigatran etexilate—Dermatitis—Valproic Acid—epilepsy syndrome	5.43e-05	0.000284	CcSEcCtD
Dabigatran etexilate—Headache—Valproic Acid—epilepsy syndrome	5.4e-05	0.000282	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Topiramate—epilepsy syndrome	5.36e-05	0.00028	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Pregabalin—epilepsy syndrome	5.33e-05	0.000278	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Topiramate—epilepsy syndrome	5.29e-05	0.000276	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Gabapentin—epilepsy syndrome	5.26e-05	0.000275	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Topiramate—epilepsy syndrome	5.19e-05	0.000271	CcSEcCtD
Dabigatran etexilate—Fatigue—Topiramate—epilepsy syndrome	5.18e-05	0.000271	CcSEcCtD
Dabigatran etexilate—Dizziness—Pregabalin—epilepsy syndrome	5.15e-05	0.000269	CcSEcCtD
Dabigatran etexilate—Constipation—Topiramate—epilepsy syndrome	5.14e-05	0.000268	CcSEcCtD
Dabigatran etexilate—Asthenia—Gabapentin—epilepsy syndrome	5.12e-05	0.000268	CcSEcCtD
Dabigatran etexilate—Nausea—Valproic Acid—epilepsy syndrome	5.12e-05	0.000267	CcSEcCtD
Dabigatran etexilate—Pruritus—Gabapentin—epilepsy syndrome	5.05e-05	0.000264	CcSEcCtD
Dabigatran etexilate—Vomiting—Pregabalin—epilepsy syndrome	4.95e-05	0.000259	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Topiramate—epilepsy syndrome	4.91e-05	0.000257	CcSEcCtD
Dabigatran etexilate—Rash—Pregabalin—epilepsy syndrome	4.91e-05	0.000257	CcSEcCtD
Dabigatran etexilate—Dermatitis—Pregabalin—epilepsy syndrome	4.91e-05	0.000256	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Gabapentin—epilepsy syndrome	4.89e-05	0.000255	CcSEcCtD
Dabigatran etexilate—Headache—Pregabalin—epilepsy syndrome	4.88e-05	0.000255	CcSEcCtD
Dabigatran etexilate—Urticaria—Topiramate—epilepsy syndrome	4.77e-05	0.000249	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Topiramate—epilepsy syndrome	4.75e-05	0.000248	CcSEcCtD
Dabigatran etexilate—Dizziness—Gabapentin—epilepsy syndrome	4.72e-05	0.000247	CcSEcCtD
Dabigatran etexilate—Nausea—Pregabalin—epilepsy syndrome	4.63e-05	0.000242	CcSEcCtD
Dabigatran etexilate—Vomiting—Gabapentin—epilepsy syndrome	4.54e-05	0.000237	CcSEcCtD
Dabigatran etexilate—Rash—Gabapentin—epilepsy syndrome	4.5e-05	0.000235	CcSEcCtD
Dabigatran etexilate—Dermatitis—Gabapentin—epilepsy syndrome	4.5e-05	0.000235	CcSEcCtD
Dabigatran etexilate—Headache—Gabapentin—epilepsy syndrome	4.47e-05	0.000234	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Topiramate—epilepsy syndrome	4.43e-05	0.000231	CcSEcCtD
Dabigatran etexilate—Asthenia—Topiramate—epilepsy syndrome	4.31e-05	0.000225	CcSEcCtD
Dabigatran etexilate—Pruritus—Topiramate—epilepsy syndrome	4.25e-05	0.000222	CcSEcCtD
Dabigatran etexilate—Nausea—Gabapentin—epilepsy syndrome	4.24e-05	0.000222	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Topiramate—epilepsy syndrome	4.11e-05	0.000215	CcSEcCtD
Dabigatran etexilate—Dizziness—Topiramate—epilepsy syndrome	3.97e-05	0.000208	CcSEcCtD
Dabigatran etexilate—Vomiting—Topiramate—epilepsy syndrome	3.82e-05	0.0002	CcSEcCtD
Dabigatran etexilate—Rash—Topiramate—epilepsy syndrome	3.79e-05	0.000198	CcSEcCtD
Dabigatran etexilate—Dermatitis—Topiramate—epilepsy syndrome	3.78e-05	0.000198	CcSEcCtD
Dabigatran etexilate—Headache—Topiramate—epilepsy syndrome	3.76e-05	0.000197	CcSEcCtD
Dabigatran etexilate—Nausea—Topiramate—epilepsy syndrome	3.57e-05	0.000186	CcSEcCtD
Dabigatran etexilate—F2—Signaling Pathways—OPRD1—epilepsy syndrome	2.1e-05	0.000244	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GNAO1—epilepsy syndrome	2.1e-05	0.000244	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—NOS2—epilepsy syndrome	2.09e-05	0.000243	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CHRM3—epilepsy syndrome	2.08e-05	0.000243	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—KCNJ11—epilepsy syndrome	2.08e-05	0.000243	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—AKT3—epilepsy syndrome	2.07e-05	0.000241	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CACNA1D—epilepsy syndrome	2.06e-05	0.00024	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CXCL12—epilepsy syndrome	2.06e-05	0.00024	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—BDKRB2—epilepsy syndrome	2.06e-05	0.00024	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CNR1—epilepsy syndrome	2.02e-05	0.000236	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—PLCB1—epilepsy syndrome	2.02e-05	0.000235	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CHRM1—epilepsy syndrome	2.01e-05	0.000234	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCR7—epilepsy syndrome	2.01e-05	0.000234	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PDYN—epilepsy syndrome	2.01e-05	0.000234	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GRM1—epilepsy syndrome	2.01e-05	0.000234	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—HTR7—epilepsy syndrome	1.97e-05	0.00023	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	1.95e-05	0.000227	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—TXNRD1—epilepsy syndrome	1.93e-05	0.000225	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—HBEGF—epilepsy syndrome	1.92e-05	0.000223	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—AGT—epilepsy syndrome	1.9e-05	0.000221	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CDC42—epilepsy syndrome	1.89e-05	0.00022	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GAL—epilepsy syndrome	1.89e-05	0.00022	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GFAP—epilepsy syndrome	1.89e-05	0.00022	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—AKT3—epilepsy syndrome	1.88e-05	0.000219	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—AQP1—epilepsy syndrome	1.87e-05	0.000218	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ADK—epilepsy syndrome	1.87e-05	0.000218	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GLUD1—epilepsy syndrome	1.87e-05	0.000218	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PDXK—epilepsy syndrome	1.87e-05	0.000218	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—FAR1—epilepsy syndrome	1.87e-05	0.000218	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CERS1—epilepsy syndrome	1.87e-05	0.000218	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—L2HGDH—epilepsy syndrome	1.87e-05	0.000218	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CHRM3—epilepsy syndrome	1.87e-05	0.000218	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CASP2—epilepsy syndrome	1.87e-05	0.000218	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GRM5—epilepsy syndrome	1.87e-05	0.000218	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	1.86e-05	0.000217	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—APOE—epilepsy syndrome	1.86e-05	0.000217	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—VEGFA—epilepsy syndrome	1.86e-05	0.000216	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	1.83e-05	0.000214	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—AVP—epilepsy syndrome	1.83e-05	0.000213	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.8e-05	0.00021	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—AGT—epilepsy syndrome	1.8e-05	0.00021	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CX3CR1—epilepsy syndrome	1.79e-05	0.000209	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	1.78e-05	0.000208	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CHRM2—epilepsy syndrome	1.76e-05	0.000205	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—BDKRB1—epilepsy syndrome	1.76e-05	0.000205	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CX3CL1—epilepsy syndrome	1.76e-05	0.000205	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—ALB—epilepsy syndrome	1.75e-05	0.000204	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	1.72e-05	0.0002	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CDC42—epilepsy syndrome	1.72e-05	0.0002	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—EPM2A—epilepsy syndrome	1.71e-05	0.000199	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NHLRC1—epilepsy syndrome	1.71e-05	0.000199	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GAMT—epilepsy syndrome	1.71e-05	0.000199	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PNPO—epilepsy syndrome	1.71e-05	0.000199	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GABBR1—epilepsy syndrome	1.71e-05	0.000199	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ABCG2—epilepsy syndrome	1.7e-05	0.000198	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CHRM3—epilepsy syndrome	1.69e-05	0.000197	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—KCNJ11—epilepsy syndrome	1.69e-05	0.000197	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—AVP—epilepsy syndrome	1.66e-05	0.000194	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	1.66e-05	0.000193	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	1.66e-05	0.000193	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CYP2C19—epilepsy syndrome	1.66e-05	0.000193	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CYP11A1—epilepsy syndrome	1.65e-05	0.000192	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HRH3—epilepsy syndrome	1.64e-05	0.000191	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	1.63e-05	0.000191	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—OPRM1—epilepsy syndrome	1.61e-05	0.000188	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—POMC—epilepsy syndrome	1.6e-05	0.000186	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—TNF—epilepsy syndrome	1.59e-05	0.000185	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CA4—epilepsy syndrome	1.59e-05	0.000185	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—QDPR—epilepsy syndrome	1.59e-05	0.000185	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	1.59e-05	0.000185	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.58e-05	0.000184	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CCR5—epilepsy syndrome	1.56e-05	0.000181	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.55e-05	0.00018	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCR3—epilepsy syndrome	1.52e-05	0.000178	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.52e-05	0.000177	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—POMC—epilepsy syndrome	1.51e-05	0.000176	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	1.5e-05	0.000174	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—COX3—epilepsy syndrome	1.5e-05	0.000174	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CYP2D6—epilepsy syndrome	1.49e-05	0.000173	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NPY—epilepsy syndrome	1.48e-05	0.000173	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ATP2A2—epilepsy syndrome	1.48e-05	0.000173	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—CCL2—epilepsy syndrome	1.48e-05	0.000173	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	1.48e-05	0.000172	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—ALB—epilepsy syndrome	1.46e-05	0.00017	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—AGT—epilepsy syndrome	1.44e-05	0.000168	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HSPB1—epilepsy syndrome	1.43e-05	0.000167	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCL3—epilepsy syndrome	1.43e-05	0.000167	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CXCL2—epilepsy syndrome	1.43e-05	0.000167	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CRH—epilepsy syndrome	1.43e-05	0.000167	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—OXT—epilepsy syndrome	1.43e-05	0.000167	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	1.43e-05	0.000166	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CACNA2D2—epilepsy syndrome	1.42e-05	0.000165	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—KCNB1—epilepsy syndrome	1.42e-05	0.000165	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SLCO1A2—epilepsy syndrome	1.42e-05	0.000165	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PFKL—epilepsy syndrome	1.42e-05	0.000165	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SLC6A8—epilepsy syndrome	1.42e-05	0.000165	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ADRA2A—epilepsy syndrome	1.41e-05	0.000165	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CCR5—epilepsy syndrome	1.41e-05	0.000165	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—BCHE—epilepsy syndrome	1.41e-05	0.000164	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—HTR2A—epilepsy syndrome	1.38e-05	0.000161	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ABCG2—epilepsy syndrome	1.38e-05	0.000161	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	1.37e-05	0.000159	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	1.35e-05	0.000158	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CYP2C19—epilepsy syndrome	1.35e-05	0.000157	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—SLC2A1—epilepsy syndrome	1.34e-05	0.000157	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CYP11A1—epilepsy syndrome	1.34e-05	0.000156	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.34e-05	0.000156	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TSC1—epilepsy syndrome	1.33e-05	0.000155	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PTK2B—epilepsy syndrome	1.33e-05	0.000155	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PLCB1—epilepsy syndrome	1.33e-05	0.000155	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.33e-05	0.000155	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—TH—epilepsy syndrome	1.32e-05	0.000154	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.32e-05	0.000154	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—AGT—epilepsy syndrome	1.31e-05	0.000153	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—UPB1—epilepsy syndrome	1.3e-05	0.000151	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ATIC—epilepsy syndrome	1.3e-05	0.000151	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NEU1—epilepsy syndrome	1.3e-05	0.000151	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCR2—epilepsy syndrome	1.3e-05	0.000151	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—SST—epilepsy syndrome	1.3e-05	0.000151	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NTRK2—epilepsy syndrome	1.3e-05	0.000151	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	1.29e-05	0.00015	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—DUSP6—epilepsy syndrome	1.28e-05	0.00015	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PTGS2—epilepsy syndrome	1.27e-05	0.000149	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ADRA2A—epilepsy syndrome	1.27e-05	0.000148	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PLAT—epilepsy syndrome	1.26e-05	0.000147	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	1.25e-05	0.000146	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—SRC—epilepsy syndrome	1.24e-05	0.000145	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	1.22e-05	0.000143	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—BDKRB2—epilepsy syndrome	1.22e-05	0.000142	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CXCL12—epilepsy syndrome	1.22e-05	0.000142	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—POMC—epilepsy syndrome	1.22e-05	0.000142	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—PRKCB—epilepsy syndrome	1.21e-05	0.000141	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.21e-05	0.000141	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—VEGFA—epilepsy syndrome	1.21e-05	0.000141	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—IL6ST—epilepsy syndrome	1.21e-05	0.000141	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CYP2D6—epilepsy syndrome	1.21e-05	0.000141	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	1.21e-05	0.000141	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GBE1—epilepsy syndrome	1.21e-05	0.000141	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CNR1—epilepsy syndrome	1.2e-05	0.000139	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—JUNB—epilepsy syndrome	1.2e-05	0.000139	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PLCB1—epilepsy syndrome	1.19e-05	0.000139	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HTR7—epilepsy syndrome	1.17e-05	0.000136	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	1.16e-05	0.000136	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ADRA2A—epilepsy syndrome	1.15e-05	0.000134	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—BCHE—epilepsy syndrome	1.14e-05	0.000133	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ASAH1—epilepsy syndrome	1.13e-05	0.000132	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HBEGF—epilepsy syndrome	1.13e-05	0.000132	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.12e-05	0.000131	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—AKT3—epilepsy syndrome	1.11e-05	0.00013	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—HMOX1—epilepsy syndrome	1.1e-05	0.000129	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—POMC—epilepsy syndrome	1.1e-05	0.000129	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—STXBP1—epilepsy syndrome	1.1e-05	0.000129	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—SLC2A1—epilepsy syndrome	1.09e-05	0.000127	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CAT—epilepsy syndrome	1.09e-05	0.000127	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ADAM10—epilepsy syndrome	1.09e-05	0.000127	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CCL2—epilepsy syndrome	1.08e-05	0.000126	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	1.08e-05	0.000126	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PLCB1—epilepsy syndrome	1.08e-05	0.000126	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—TH—epilepsy syndrome	1.08e-05	0.000125	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ALAD—epilepsy syndrome	1.07e-05	0.000125	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NT5E—epilepsy syndrome	1.07e-05	0.000125	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.07e-05	0.000125	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ABCB1—epilepsy syndrome	1.06e-05	0.000124	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.06e-05	0.000123	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	1.05e-05	0.000122	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—S100B—epilepsy syndrome	1.03e-05	0.00012	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	1.03e-05	0.000119	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	1.03e-05	0.000119	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—SOCS3—epilepsy syndrome	1.02e-05	0.000118	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CDC42—epilepsy syndrome	1.01e-05	0.000118	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	1e-05	0.000117	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GPX1—epilepsy syndrome	9.86e-06	0.000115	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ADSL—epilepsy syndrome	9.83e-06	0.000115	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—AVP—epilepsy syndrome	9.82e-06	0.000114	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GLUL—epilepsy syndrome	9.64e-06	0.000112	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	9.46e-06	0.00011	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	9.41e-06	0.00011	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HES1—epilepsy syndrome	9.28e-06	0.000108	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	9.16e-06	0.000107	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—FYN—epilepsy syndrome	9.03e-06	0.000105	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—H2AFX—epilepsy syndrome	9e-06	0.000105	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MEF2C—epilepsy syndrome	8.98e-06	0.000105	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—HMOX1—epilepsy syndrome	8.98e-06	0.000105	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CAT—epilepsy syndrome	8.86e-06	0.000103	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	8.85e-06	0.000103	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	8.79e-06	0.000102	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	8.72e-06	0.000102	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—YWHAZ—epilepsy syndrome	8.68e-06	0.000101	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—AGT—epilepsy syndrome	8.65e-06	0.000101	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ABCB1—epilepsy syndrome	8.62e-06	0.0001	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—AQP1—epilepsy syndrome	8.59e-06	0.0001	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NGF—epilepsy syndrome	8.58e-06	0.0001	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—APOE—epilepsy syndrome	8.47e-06	9.87e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCR5—epilepsy syndrome	8.35e-06	9.73e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HTR2A—epilepsy syndrome	8.17e-06	9.52e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GPX1—epilepsy syndrome	8.01e-06	9.34e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	7.85e-06	9.15e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CHRM3—epilepsy syndrome	7.77e-06	9.06e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	7.77e-06	9.06e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TSC2—epilepsy syndrome	7.76e-06	9.04e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—AGT—epilepsy syndrome	7.75e-06	9.03e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—AKT1—epilepsy syndrome	7.71e-06	8.99e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—APOE—epilepsy syndrome	7.59e-06	8.85e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—KDR—epilepsy syndrome	7.44e-06	8.67e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—POMC—epilepsy syndrome	7.28e-06	8.48e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PRKCB—epilepsy syndrome	7.16e-06	8.35e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IL6ST—epilepsy syndrome	7.13e-06	8.31e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—AGT—epilepsy syndrome	7.03e-06	8.19e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—APOE—epilepsy syndrome	6.88e-06	8.02e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ALB—epilepsy syndrome	6.63e-06	7.73e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—POMC—epilepsy syndrome	6.52e-06	7.6e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—AKT1—epilepsy syndrome	6.4e-06	7.46e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCL2—epilepsy syndrome	6.38e-06	7.44e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ABCG2—epilepsy syndrome	6.33e-06	7.38e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	6.17e-06	7.19e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	6.13e-06	7.15e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—POMC—epilepsy syndrome	5.91e-06	6.89e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	5.85e-06	6.81e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PTGS2—epilepsy syndrome	5.8e-06	6.76e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—FGF2—epilepsy syndrome	5.77e-06	6.72e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	5.54e-06	6.45e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ALB—epilepsy syndrome	5.39e-06	6.28e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—RELA—epilepsy syndrome	5.36e-06	6.24e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	5.28e-06	6.15e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	5.27e-06	6.14e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MTOR—epilepsy syndrome	5.25e-06	6.12e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—BCHE—epilepsy syndrome	5.25e-06	6.12e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	5.01e-06	5.84e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PLCB1—epilepsy syndrome	4.95e-06	5.77e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—TH—epilepsy syndrome	4.93e-06	5.75e-05	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—AKT1—epilepsy syndrome	4.88e-06	5.68e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CASP3—epilepsy syndrome	4.83e-06	5.63e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PTGS2—epilepsy syndrome	4.72e-06	5.5e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—JUN—epilepsy syndrome	4.69e-06	5.47e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MMP9—epilepsy syndrome	4.56e-06	5.32e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—AKT1—epilepsy syndrome	4.43e-06	5.16e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—SRC—epilepsy syndrome	4.21e-06	4.9e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—HMOX1—epilepsy syndrome	4.12e-06	4.8e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—VEGFA—epilepsy syndrome	4.1e-06	4.78e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CAT—epilepsy syndrome	4.06e-06	4.74e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GPX1—epilepsy syndrome	3.68e-06	4.28e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—AGT—epilepsy syndrome	3.22e-06	3.76e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—APOE—epilepsy syndrome	3.16e-06	3.68e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—AKT1—epilepsy syndrome	2.92e-06	3.4e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—POMC—epilepsy syndrome	2.71e-06	3.16e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—AKT1—epilepsy syndrome	2.62e-06	3.05e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ALB—epilepsy syndrome	2.47e-06	2.88e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—AKT1—epilepsy syndrome	2.37e-06	2.76e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PTGS2—epilepsy syndrome	2.16e-06	2.52e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.09e-06	1.27e-05	CbGpPWpGaD
